Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report

Neurology

Volumn 71, Issue 17, 2008, Pages 1355-1360

  Grimm, S A ^a   McCannel, C A ^b   Omuro, A M P ^c   Ferreri, A J M ^d   Blay, J Y ^d   Neuwelt, E A ^e   Siegal, T ^f   Batchelor, T ^g   Jahnke, K ^h   Shenkier, T N ⁱ   Hall, A J ^j   Graus, F ^k   Herrlinger, U ^l   Schiff, D ^m   Raizer, J ⁿ   Rubenstein, J ^o   Laperriere, N ^p   Thiel, E ^h   Doolittle, N ^e   Iwamoto, F M ^a   Abrey, L E ^a   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d International Extranodal Lymphoma Study Group   (Switzerland)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ BRITISH COLUMBIA CANCER AGENCY   (Canada)

^j ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^k HOSPITAL CLÍNIC   (Spain)

^l UNIVERSITY OF TÜBINGEN   (Germany)

^m UNIVERSITY OF VIRGINIA   (United States)

ⁿ NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p PRINCESS MARGARET HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; HISTONE DEACETYLASE INHIBITOR; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; APHASIA; ARTICLE; ATAXIA; B LYMPHOCYTE; BEHAVIOR CHANGE; BLURRED VISION; BRAIN BIOPSY; BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CEREBROSPINAL FLUID CYTOLOGY; CHOROID; COGNITIVE DEFECT; CONTROLLED STUDY; EYE BIOPSY; FEMALE; HEADACHE; HEMIPARESIS; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; INTRAOCULAR TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RETINA; RETROSPECTIVE STUDY; SEIZURE; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR BIOPSY; VISUAL ACUITY; VITRECTOMY; WHOLE BODY RADIATION; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; COOPERATION; EYE TUMOR; FOLLOW UP; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; RESEARCH; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; COOPERATIVE BEHAVIOR; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONALITY; LYMPHOMA; MALE; MIDDLE AGED; RESEARCH; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 55449111364     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000327672.04729.8c     Document Type: Article

References (20)

1. Choi JY, Kafkala C, Foster CS. Primary intraocular lymphoma: a review. Semin Ophthalmol 2006;21:125- 133.
2. Nussenblatt RB, Chan CC, Wilson WH, Hochman J, Gottesman M. International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future. Ocul Immunol Inflamm 2006;14:139-144.
3. Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol 2007;18:1851-1855.
4. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
5. Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control 2004; 11:285-295.
6. Bernstein M, Parrent AG. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 1994;81:165-168.
7. Kulkarni AV, Guha A, Lozano A, Bernstein M. Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 1998;89: 31-35.
8. Balmaceda C, Gaynor JJ, Sun M, Gluck JT, DeAngelis LM. Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol 1995;38:202-209.
9. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000; 18:3144-3150.
10. Batchelor T, Carson K, O'Neill A, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 2003;21:1044-1049.
11. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 2002;20:4643-4648.
12. DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992;10:635-643.
13. Ferreri AJ, Reni M, Dell'Oro S, et al. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lym-phoma in immunocompetent patients. Oncology 2001; 60:134-140.
14. Glass J, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994; 81:188-195.
15. Ferreri AJ, Blay JY, Reni M, et al. Prognostic scoring system for primary CNS lymphomas: the International Ex-tranodal Lymphoma Study Group experience. J Clin Oncol 2003;15:266-272.
16. Abrey LE, Ben-Porat L, Panageas KS, et al. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 2006;24: 5711-5715.
17. Batchelor TT, Kolak G, Ciordia R, Foster CS, Henson JE. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 2003;9:711-717.
18. Soussain C, Suzan F, Hoang-Xuan K, et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 2001;19:742-749.
19. Isobe K, Ejima Y, Tokumaru S, et al. Treatment of primary intraocular lymphoma with radiation therapy: a multi-institutional survey in Japan. Leuk Lymphoma 2006;47:1800-1805.
20. Frenkel S, Hendler K, Siegal T, Shalom E, Pe'er J. In-travitreal methotrexate for treating vitreoretinal lym-phoma: 10 years of experience. Br J Ophthal 2008;92: 383-388.